Overview
Genomic Health
?
Kevin T Conroy
See more contacts
Medical and Diagnostic Laboratories
,
Scientific Research and Development Services
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Medical laboratories
See All Industries Biotechnical research, commercial
See Fewer Industries
See All Industries Biotechnical research, commercial
See Fewer Industries
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Modelled
?
Actual
#
Actual
? %
?
?
?
Contacts
Get in Touch with 2 Principals* and 141 Contacts
-
Kevin T ConroyPresident
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of ? (12 month period) in USD
Annual Revenue
?
USD
Modelled
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2018 | 2017 | 2016 |
|---|---|---|---|
| Net Operating Cash | $77 | $31 | $13 |
| Net Investing Cash | -$81 | -$43 | -$19 |
| Net Financing Cash | $21 | $17 | $14 |
| Net Change in Cash | $16 | $5 | $8 |
| Cash at Beginning of Period | $46 | $41 | $33 |
| Cash at End of Period | $62 | $46 | $41 |
| Capital Expenditure | -$10 | -$13 | -$20 |
| Assets (mil) | 2018 | 2017 | 2016 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $62 | $46 | $40 |
| Accounts Receivable | $52 | $31 | $35 |
| Inventories | $ | $ | $ |
| Other Current Assets | $162 | $98 | $70 |
| Asset Summary | |||
| Total Current Assets | $275 | $174 | $146 |
| Tangible Fixed Assets | $40 | $46 | $46 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $334 | $232 | $201 |
| Liabilities (mil) | 2018 | 2017 | 2016 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $9 | $0 | $3 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $51 | $39 | $38 |
| Liability Summary | |||
| Total Current Liabilities | $60 | $40 | $41 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $4 | $4 | $4 |
| Total Liabilities | $64 | $43 | $45 |
| Stakeholder's Equity (mil) | 2018 | 2017 | 2016 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$206 | -$246 | -$242 |
| Equity Summary | |||
| Total Equity | $270 | $188 | $156 |
| Shares Outstanding | 36,407,287 | 35,049,436 | 33,831,998 |